Abstract:Hepatocellular carcinoma (HCC) is a fatal digestive system cancer with unclear pathogenesis. M‐phase phosphoprotein 8 (MPP8) has been shown to play a vital role in several cancer types, such as non‐small cell lung cancer, gastric cancer and melanoma; however, there have been no studies into its role in HCC. The present study aimed to evaluate the role of MPP8 in regulating malignant phenotypes of liver cancer cells, and to further investigate the underlying mechanism. Bioinformatics analysis was performed to analyze related data from a public database, and to predict the potential microRNAs (miRNAs) that might target MPP8 mRNA; reverse transcription-quantitative PCR was used to measure the levels of mRNA and miRNA; western blotting was employed to detect protein levels; Cell Counting Kit‐8 (CCK‐8) and plate colony formation assays, wound healing assay and Transwell invasion assay were performed to evaluate the ability of cell proliferation, migration and invasion, respectively; dual‐luciferase reporter gene assay was performed to identify the target association. The results showed that MPP8 was a risk factor for the survival of patients with HCC, and was up‐regulated in HCC tissue samples and cell lines; MPP8 knockdown inhibited the proliferation, migration and invasion of liver cancer cells; MPP8 knockdown suppressed the PI3K/Akt pathway, and activation of this pathway reversed the inhibited liver cancer cell phenotypes by down‐regulating MPP8; miR‐576‐3p, which was low in liver cancer cells, negatively regulated MPP8 expression by directly targeting its mRNA; up‐regulating MPP8 expression reversed the inhibited signaling pathway and malignant phenotypes of liver cancer cells by miR‐576‐3p overexpression. In conclusion, the miR‐576‐3p/MPP8 axis regulates the proliferation, migration, and invasion of liver cancer cells through the PI3K/Akt signaling pathway. These findings lead novel insights into HCC progression, and propose MPP8 as a potential therapeutic target for HCC.

miR‐576‐3p/M‐phase phosphoprotein 8 axis regulates the malignant progression of hepatocellular carcinoma cells via the PI3K/Akt signaling pathway

LncRNA MEG8 Plays an Oncogenic Role in Hepatocellular Carcinoma Progression Through Mir-367-3p/14-3-3ζ/tgfβr1 Axis.

MNS1 Promotes Hepatocarcinogenesis and Metastasis Via Activating PI3K/AKT by Translocating Β‐catenin and Predicts Poor Prognosis

Regulatory MiR‐148a‐ACVR1/BMP Circuit Defines a Cancer Stem Cell‐like Aggressive Subtype of Hepatocellular Carcinoma

MicroRNA-337 Regulates the PI3K/AKT and Wnt/β-catenin Signaling Pathways to Inhibit Hepatocellular Carcinoma Progression by Targeting High-Mobility Group AT-hook 2.

MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.

miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway

M-phase Phosphoprotein 8 Promotes Gastric Cancer Growth and Metastasis Via P53/bcl-2 and EMT-related Signalling Pathways

MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8

MicroRNA-183-5p Contributes to Malignant Progression Through Targeting PDCD4 in Human Hepatocellular Carcinoma.

MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.

miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/?-catenin signaling pathway

Mir-128-3p Suppresses Hepatocellular Carcinoma Proliferation by Regulating Pik3r1 and is Correlated with the Prognosis of Hcc Patients

Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression

Molecular Mechanism of the Mir-7/Bcl2l1/p53 Signaling Axis Regulating the Progression of Hepatocellular Carcinoma

Down-regulation of MAP2K1 by Mir-539 Inhibits Hepatocarcinoma Progression.

CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p/PTK2/AKT axis

Repressing Phosphatidylinositol-4,5-bisphosphate 3-Kinase Catalytic Subunit Gamma by Microrna-142-3p Restrains the Progression of Hepatocellular Carcinoma

Data from MPHOSPH1: A Potential Therapeutic Target for Hepatocellular Carcinoma

Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell